Alixia: Funding, Investors & Team (Oct 2026)
Alixia is actively involved in medical research to find innovative solutions to combat cancer, aging, and inflammation. The company combines various scientific disciplines such as integrated biology, biophysics, computational chemistry, and clinical insights to develop cutting-edge therapeutic advancements. Alixia's main focus is on identifying lead compounds that target metabolic and inflammatory pathways in cancer cells and pre-cancerous cells in the surrounding environment.
Alixia has raised $1.8M across 1 funding round on record, the most recent a Seed of $1.8M announced in Jul 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Alixia Company Profile and Key Stats
Latest funding round on record: Jul 2024.
Alixia Funding Rounds
Alixia Founders and Leadership Team
Contact details for the Alixia team: 1 of 1 has an email address on file.
Start 14-day free trial →Alixia Funding Compared to Other Biotechnology Startups
Alixia's latest round of $1.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Alixia in Biotechnology and San Francisco
Companies Similar to Alixia
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Alixia Funding FAQs
What does Alixia do?
Alixia is actively involved in medical research to find innovative solutions to combat cancer, aging, and inflammation. The company combines various scientific disciplines such as integrated biology, biophysics, computational chemistry, and clinical insights to develop cutting-edge therapeutic advancements. Alixia's main focus is on identifying lead compounds that target metabolic and inflammatory pathways in cancer cells and pre-cancerous cells in the surrounding environment.
How much funding has Alixia raised?
Alixia has raised $1.8M across 1 round on record. The most recent is a Seed of $1.8M announced in Jul 2024.
When did Alixia last raise funding?
Alixia's most recent funding round on record is a Seed of $1.8M, announced in Jul 2024.
Who founded Alixia?
FundedIQ lists Olof Mollstedt (Founder) at Alixia.
Where is Alixia headquartered?
Alixia is based in San Francisco, California, United States.
How many employees does Alixia have?
Alixia is in the 1-10 employee band.
How does Alixia's funding compare to other Biotechnology startups?
Alixia's latest round of $1.8M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Alixia Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alixia is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.